{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:10:09Z","timestamp":1789711809787,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01577-w","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:53:58Z","timestamp":1784274838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal trends and demographic patterns in multiple myeloma incidence in the United States: a 24-year analysis of the CDC WONDER database (1999\u20132022)"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7261-5964","authenticated-orcid":false,"given":"Sidharth","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav Singh","family":"Oberoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Massat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3428-1667","authenticated-orcid":false,"given":"Patrick Alan","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"1577_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327:464\u201377.","journal-title":"JAMA"},{"key":"1577_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:1086\u2013107.","journal-title":"Am J Hematol"},{"key":"1577_CR3","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3324\/haematol.2020.247015","volume":"105","author":"A Gulla","year":"2020","unstructured":"Gulla A, Anderson KC. Multiple myeloma: the (r)evolution of current therapy and a glance into future. Haematologica. 2020;105:2358\u201367.","journal-title":"Haematologica"},{"key":"1577_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70224","volume":"9","author":"NJ Bahlis","year":"2025","unstructured":"Bahlis NJ, Nooka AK, DiBonaventura M, Sullivan ST, Chaudhary MA, Aydin D, et al. The impact of reduced dosing frequency of elranatamab on patient-reported outcomes in patients with relapsed or refractory multiple myeloma: results from MagnetisMM-3. HemaSphere. 2025;9:e70224.","journal-title":"HemaSphere"},{"key":"1577_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ Van de Donk","year":"2021","unstructured":"Van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397:410\u201327.","journal-title":"Lancet"},{"key":"1577_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.33696\/haematology.4.055","volume":"4","author":"MJ Nieto","year":"2023","unstructured":"Nieto MJ, Hedjar A, Locke M, Caro J, Saif MW. Analysis of updates in multiple myeloma treatment and management. J Clin Haematol. 2023;4:35\u201342.","journal-title":"J Clin Haematol"},{"key":"1577_CR7","doi-asserted-by":"publisher","first-page":"8115","DOI":"10.1200\/jco.2010.28.15_suppl.8115","volume":"28","author":"AJ Waxman","year":"2010","unstructured":"Waxman AJ, Mink P, Devesa S, Anderson WF, Weiss BM, Kristinsson S, et al. Racial disparities in incidence and survival among 37,977 blacks and whites with multiple myeloma. J Clin Oncol. 2010;28:8115.","journal-title":"J Clin Oncol"},{"key":"1577_CR8","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1182\/blood.V114.22.1832.1832","volume":"114","author":"O Landgren","year":"2009","unstructured":"Landgren O, Devesa S, Mink P, Anderson WF, Weiss B, Kristinsson SY, et al. African-American multiple myeloma patients have a better survival than caucasian patients: a population-based study including 28,636 Patients. Blood. 2009;114:1832.","journal-title":"Blood"},{"key":"1577_CR9","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMra2412716","volume":"393","author":"SV Rajkumar","year":"2025","unstructured":"Rajkumar SV, Kumar S. Monoclonal gammopathy of undetermined significance. N Engl J Med. 2025;393:1315\u201326.","journal-title":"N Engl J Med"},{"key":"1577_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0284-7","volume":"10","author":"CR Marinac","year":"2020","unstructured":"Marinac CR, Ghobrial IM, Birmann BM, Soiffer J, Rebbeck TR. Dissecting racial disparities in multiple myeloma. Blood Cancer J. 2020;10:19.","journal-title":"Blood Cancer J"},{"key":"1577_CR11","unstructured":"United States Cancer Statistics \u2013 Incidence: 1999\u20132022, WONDER Online Database. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2024 submission; 2025 release. Accessed January 30, 2026. Available from: https:\/\/wonder.cdc.gov\/cancer.html."},{"key":"1577_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00588-z","volume":"11","author":"J Martinez-Lopez","year":"2021","unstructured":"Martinez-Lopez J, Hernandez-Ibarburu G, Alonso R, Sanchez-Pina JM, Zamanillo I, Lopez-Mu\u00f1oz N, et al. Impact of COVID-19 in patients with multiple myeloma based on a global data network. Blood Cancer J. 2021;11:198.","journal-title":"Blood Cancer J"},{"key":"1577_CR13","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348.","journal-title":"Lancet Oncol"},{"key":"1577_CR14","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE III, et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 2022;9:e670\u20137.","journal-title":"Lancet Haematol"},{"key":"1577_CR15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362\u20139.","journal-title":"N Engl J Med"},{"key":"1577_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ejh.13083","volume":"101","author":"I Turesson","year":"2018","unstructured":"Turesson I, Bjorkholm M, Blimark CH, Kristinsson S, Velez R, Landgren O. Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival. Eur J Haematol. 2018;101:237\u201344.","journal-title":"Eur J Haematol"},{"key":"1577_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.12703\/r\/11-34","volume":"11","author":"JP Abeykoon","year":"2022","unstructured":"Abeykoon JP, Tawfiq RK, Kumar S, Ansell SM. Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyond. Fac Rev. 2022;11:34.","journal-title":"Fac Rev"},{"key":"1577_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/10408363.2023.2209652","volume":"60","author":"C Wijnands","year":"2023","unstructured":"Wijnands C, Noori S, Donk NWCJV, VanDuijn MM, Jacobs JFM. Advances in minimal residual disease monitoring in multiple myeloma. Crit Rev Clin Lab Sci. 2023;60:518\u201334.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1577_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47906-y","volume":"13","author":"SE Mousavi","year":"2023","unstructured":"Mousavi SE, Ilaghi M, Aslani A, Yekta Z, Nejadghaderi SA. A population-based study on incidence trends of myeloma in the United States over 2000\u20132020. Sci Rep. 2023;13:20705.","journal-title":"Sci Rep"},{"key":"1577_CR20","doi-asserted-by":"publisher","first-page":"e20052","DOI":"10.1200\/JCO.2023.41.16_suppl.e20052","volume":"41","author":"AK Ghosh","year":"2023","unstructured":"Ghosh AK, McGuire N, Ruiz Vega R, Alaws H, Adewunmi C, Abidoye O, et al. Identifying associations between race and gender in the incidence and mortality of patients with multiple myeloma. J Clin Oncol. 2023;41:e20052.","journal-title":"J Clin Oncol"},{"key":"1577_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41223-8","volume":"14","author":"JH Huber","year":"2023","unstructured":"Huber JH, Ji M, Shih YH, Wang M, Colditz G, Chang SH. Disentangling age, gender, and racial\/ethnic disparities in multiple myeloma burden: a modeling study. Nat Commun. 2023;14:5768.","journal-title":"Nat Commun"},{"key":"1577_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s10585-024-10305-2","volume":"41","author":"MH Elbahoty","year":"2024","unstructured":"Elbahoty MH, Papineni B, Samant RS. Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics. Clin Exp Metastasis. 2024;41:829\u201342.","journal-title":"Clin Exp Metastasis"},{"key":"1577_CR23","first-page":"111","volume":"75","author":"AH Saka","year":"2025","unstructured":"Saka AH, Giaquinto AN, McCullough LE, Tossas KY, Star J, Jemal A, et al. Cancer statistics for African American and Black people, 2025. CA: CA Cancer J Clin. 2025;75:111\u201340.","journal-title":"CA: CA Cancer J Clin"},{"key":"1577_CR24","doi-asserted-by":"crossref","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, et al. Body Fatness and Cancer \u2014 Viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794\u20138.","DOI":"10.1056\/NEJMsr1606602"},{"key":"1577_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00961-0","volume":"13","author":"M Bhutani","year":"2023","unstructured":"Bhutani M, Blue BJ, Cole C, Badros AZ, Usmani SZ, Nooka AK, et al. Addressing the disparities: the approach to the African American patient with multiple myeloma. Blood Cancer J. 2023;13:189.","journal-title":"Blood Cancer J"},{"key":"1577_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1200\/JCO.18.02096","volume":"37","author":"J Mikhael","year":"2019","unstructured":"Mikhael J, Ismaila N, Cheung MC, Costello C, Dhodapkar MV, Kumar S, et al. Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline. J Clin Oncol. 2019;37:1228\u201363.","journal-title":"J Clin Oncol"},{"key":"1577_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/10428194.2023.2273746","volume":"65","author":"A Saunders","year":"2024","unstructured":"Saunders A, Slaff S, Subbiah K, Gu T, Ang KK, Quan MA, et al. Clinical characteristics, treatment patterns, and outcomes among African American and White patients with multiple myeloma in the United States. Leuk. Lymphoma. 2024;65:109\u201317.","journal-title":"Leuk. Lymphoma"},{"key":"1577_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1158\/1940-6207.CAPR-24-0199","volume":"18","author":"AJ Normann","year":"2025","unstructured":"Normann AJ, Wilson RL, Matarese E, Lu C, Ranieri BP, Gardiner JR, et al. Racial health disparity and risk of multiple myeloma: implications for energy balance interventions. Cancer Prev Res. 2025;18:261\u20139.","journal-title":"Cancer Prev Res"},{"key":"1577_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1282569","volume":"13","author":"R Vijjhalwar","year":"2023","unstructured":"Vijjhalwar R, Song K, Shrestha R, Bowcock S, Sanchez-Santos MT, Ramasamy K, et al. Patient-reported symptoms and diagnostic journey in multiple myeloma. Front Oncol. 2023;13:1282569.","journal-title":"Front Oncol"},{"key":"1577_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01311-y","volume":"15","author":"LG Rodr\u00edguez-Lobato","year":"2025","unstructured":"Rodr\u00edguez-Lobato LG, de Daniel A, Pereira A, Fern\u00e1ndez de Larrea C, Tovar N, Cibeira MT, et al. Attrition rates and treatment outcomes in multiple myeloma: real-world data over a 40-year period. Blood Cancer J. 2025;15:103.","journal-title":"Blood Cancer J"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01577-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01577-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01577-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:57:49Z","timestamp":1789711069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01577-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01577-w","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"158"}}